Table 2 Summary of results for twenty-two prostate plans, showing average relative % differences between SC and MC calculated dose-volume indices including standard deviation and the range of dose-volume indices.

D₉₈

[-3.8, 0.06]

1.2 ± 1.1 (p < 0.05)

D₅₀

[-3.2, 0.9]

0.8 ± 1.0 (p < 0.05)

D₂

[-0.5, 4.2]

1.4 ± 1.4 (p < 0.05)

D_mean

[-2.5, 2.9]

0.3 ± 1.1 (p > 0.05)

D₉₅

[-4.7, 0.6]

1.5 ± 1.4 (p < 0.05)

D₅₀

[-3.0, 1.0]

0.4 ± 1.3 (p > 0.05)

D₂

[-2.1, 2.6]

0.1 ± 1.1 (p > 0.05)

D_mean

[-2.9, 1.4]

0.3 ± 1.2 (p > 0.05)

D₅₀

[-3.6, 3.4]

0.2 ± 1.8 (p > 0.05)

D₁₀

[-2.9, 2.2]

0.3 ± 1.5 (p > 0.05)

D₂

[-2.5, 1.9]

0.4 ± 1.2 (p > 0.05)

D_mean

[-2.9, 3.1]

0.6 ± 1.7 (p > 0.05)

D₅₀

[-3.7, 1.4]

0.9 ± 1.4 (p < 0.05)

D₁₀

[-3.2, 1.5]

0.7 ± 1.3 (p < 0.05)

D₂

[-2.7, 2.2]

0.7 ± 1.1 (p < 0.05)

D_mean

[-3.8, 0.9]

0.8 ± 1.3 (p < 0.05)

D₅₀

[0.2, 115]

30.2 ± 40.7 (p < 0.05)

D₁₀

[-3.1, 120.7]

10.1 ± 26.4 (p < 0.05)

D₂

[-2.6, 100.1]

6.8 ± 21.5 (p < 0.05)

D_mean

[-1.5, 123.5]

16.5 ± 27.5 (p < 0.05)

D₅₀

[1.2, 14.5]

8.6 ± 3.6 (p < 0.05)

D₁₀

[-3.0, 8.4]

4.6 ± 3.5 (p < 0.05)

D₂

[-2.9, 8.6]

4.1 ± 3.3 (p < 0.05)

D_mean

[-0.9, 10.3]

6.3 ± 3.9 (p < 0.05)

D₂

[1.7, 12.1]

7.7 ± 3.8 (p < 0.05)